More tools:Markets·Screener·Research Chat

Novartis AG (NVS) Financial Statements

Novartis AG
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SF5LW6
XNYS · usd
150.36▼ 3.01 (-1.96%)
As of 2026-07-14
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)—
Net Income (TTM)$14.0B
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close153.37
Day's Range150.33 – 152.44
52-Week Range112.34 – 170.48
Volume1.20M
Avg Volume2.11M
Share Statistics
Shares Outstanding2.0B
Employees75.3K
ExchangeXNYS
Listed1996-11-07

Key questions about Novartis AG (NVS)

What is Novartis AG's Market Cap?
Novartis AG's Market Cap is $306.0B, based on as-reported figures from SEC (XBRL) filings.
What is Novartis AG's Enterprise Value?
Novartis AG's Enterprise Value is $293.9B, based on as-reported figures from SEC (XBRL) filings.
What is Novartis AG's Trailing P/E?
Novartis AG's Trailing P/E is 21.9×, based on as-reported figures from SEC (XBRL) filings.
What is Novartis AG's Net Income (TTM)?
Novartis AG's Net Income (TTM) is $14.0B, based on as-reported figures from SEC (XBRL) filings.
What is Novartis AG's Diluted EPS (TTM)?
Novartis AG's Diluted EPS (TTM) is 6.86, based on as-reported figures from SEC (XBRL) filings.
What is Novartis AG's Net Debt?
Novartis AG's Net Debt is $0.00, based on as-reported figures from SEC (XBRL) filings.

No financial data found for NVS

Try a different ticker. We may not have processed this company's filings yet.